Celestial Biolabs announced that the 25th Annual General Meeting (AGM) of the company will be held on 23 May 2024.Powered by Capital Market - Live News

Net Loss of Celestial Biolabs reported to Rs 0.04 crore in the quarter ended December 2023 as against net loss of Rs 0.15 crore during the previous quarter ended December 2022. Sales rose 33.33% to Rs 0.04 crore in the quarter ended December 2023 as against Rs 0.03 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales0.040.03 33 OPM %-75.00-500.00 - PBDT-0.03-0.15 80 PBT-0.04-0.15 73 NP-0.04-0.15 73 Powered by Capital Market - Live News

Net Loss of Celestial Biolabs reported to Rs 0.03 crore in the quarter ended December 2023 as against net loss of Rs 0.15 crore during the previous quarter ended December 2022. Sales rose 33.33% to Rs 0.04 crore in the quarter ended December 2023 as against Rs 0.03 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales0.040.03 33 OPM %-50.00-466.67 - PBDT-0.02-0.14 86 PBT-0.03-0.15 80 NP-0.03-0.15 80 Powered by Capital Market - Live News

Celestial Biolabs will hold a meeting of the Board of Directors of the Company on 29 March 2024.Powered by Capital Market - Live News

Celestial Biolabs has cancelled the board meeting which was scheduled to be held on 6 March 2024.Powered by Capital Market - Live News